DUHUNTX
Live / Allowed — Published for opposition (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99715547
- Mark type
- Word mark
- Filed
- 20 Mar 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Peter Kunin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease
Owner
- Skyhawk Therapeutics, Inc., Waltham, MA, US
- Skyhawk Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2026 — ASSIGNED TO EXAMINER
- 20 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Mar 2026 — NEW APPLICATION ENTERED